Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Investment Outlook For China And India Too Hot? VCs Anticipate Market Corrections - PharmAsia Summit

This article was originally published in PharmAsia News

Executive Summary

SAN FRANCISCO - Investors have not felt the pinch of the financial crisis in China and India as much as they have in the West, investors told PharmAsia Summit attendees in San Francisco Oct. 28

You may also be interested in...



PharmAsia News' Top Industry Trends Of 2009

As PharmAsia News wraps up its second year of publishing, we look back to some of the top trends and stories of 2009, as well as developing stories to keep an eye on in 2010

PharmAsia News' Top Industry Trends Of 2009

As PharmAsia News wraps up its second year of publishing, we look back to some of the top trends and stories of 2009, as well as developing stories to keep an eye on in 2010

Roche, McKinsey and OrbiMed Launch First Life Sciences Business Plan Competition In Shanghai

SHANGHAI - Swiss-headquartered Roche, business consulting company McKinsey and venture capitalist OrbiMed co-launched Dec.10 their Shanghai SEED competition to foster entrepreneurs in China's life sciences sector

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

SC070518

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel